1995
DOI: 10.1016/0378-5122(94)00861-z
|View full text |Cite
|
Sign up to set email alerts
|

The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
29
0

Year Published

2000
2000
2017
2017

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(32 citation statements)
references
References 15 publications
3
29
0
Order By: Relevance
“…Decreased levels of HDL-cholesterol have been reported following testosterone administration in female to male transsexuals (45). For the combined testosteroneϩestrogen treatment, our results are in agreement with those of Flöter and co-workers (23), except that they also observed a significant decrease in HDL-cholesterol, as did Watts and coworkers who used a similar treatment regimen (10).…”
Section: Zang Effects Of Testosterone In Women Fertil Steril 2006supporting
confidence: 95%
“…Decreased levels of HDL-cholesterol have been reported following testosterone administration in female to male transsexuals (45). For the combined testosteroneϩestrogen treatment, our results are in agreement with those of Flöter and co-workers (23), except that they also observed a significant decrease in HDL-cholesterol, as did Watts and coworkers who used a similar treatment regimen (10).…”
Section: Zang Effects Of Testosterone In Women Fertil Steril 2006supporting
confidence: 95%
“…Two prospective studies indicate a decrease in HDL and triglycerides, with no change in LDL, among FtM patients on testosterone therapy (Berra et al, 2006;Elbers et al, 2003), while another study demonstrated an increase in LDL and a decrease in HDL (Goh, Loke, & Ratnam, 1995). Retrospective studies in the transgender population show mixed changes in LDL and decreases in HDL cholesterol (Asscheman et al, 1994;Futterweit, 1998;McCredie et al, 1998).…”
Section: Masculinizing Hormone Therapy (Ftm): Physiological Consideramentioning
confidence: 93%
“…Female-to-male transsexuals using pharmacologic doses of T, which increases the serum T into the mid-to-high normal range for males, experience increased total cholesterol, low-density lipoprotein (LDL) cholesterol, apolipoprotein-B, and triglycerides and decreased high-density lipoprotein (HDL) cholesterol with pharmacological quantities of IM T, which increase the serum T into the high normal range for males (58,80). In the trials of postmenopausal women receiving estrogen and oral MT, the total cholesterol decreased by 6%-17%; HDL was reduced as much as 26%; and the changes in LDL were variable, going from a 7% increase to a 19.3% decrease.…”
Section: Lipidsmentioning
confidence: 99%